ÜBER DIESE EPISODE
Join us for a conversation on how artificial intelligence is advancing cancer prevention, early detection, and treatment, in recognition of National Cancer Prevention and Early Detection Month. This session features Virginie Buggia-Prevot (ValoHealth), Bahar Rahsepar (PathAI), and Paola Rodriguez (micro1), moderated by Mark Esposito (micro1).
We’ll explore how AI is accelerating drug discovery, enabling more accurate and scalable diagnostics, and supporting clinicians through human-in-the-loop systems, while addressing critical challenges such as data quality, bias, interpretability, and the gap between research innovation and real-world clinical deployment.
Speakers: Virginie Buggia-Prevot, PhD. -Executive Director at ValoHealth & Paola Rodriguez MD., Director of Medical Research at micro1 & Bahar Rahsepar, PhD. - Associate Director of AI Products at PathAI
Moderated by: Mark Esposito, PhD. - Chief Economist, micro1
